Moneycontrol
SENSEX NIFTY
you are here:

IOL Chemicals and Pharmaceuticals Ltd.

BSE: 524164 | NSE: IOLCP |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE485C01011 | SECTOR: Pharmaceuticals

BSE Live

Jul 10, 16:00
695.45 71.80 (11.51%)
Volume
AVERAGE VOLUME
5-Day
358,546
10-Day
288,730
30-Day
198,213
743,258
  • Prev. Close

    623.65

  • Open Price

    639.80

  • Bid Price (Qty.)

    695.45 (967)

  • Offer Price (Qty.)

    695.45 (1)

NSE Live

Jul 10, 15:59
695.25 71.90 (11.53%)
Volume
AVERAGE VOLUME
5-Day
2,889,184
10-Day
2,302,352
30-Day
1,835,325
6,605,379
  • Prev. Close

    623.35

  • Open Price

    637.00

  • Bid Price (Qty.)

    695.25 (2057)

  • Offer Price (Qty.)

    0.00 (0)

ANNOUNCEMENTS ON IOL Chemicals

  • Jul 11, 2020 13:22 Source: BSE

    IOL Chemicals and Pharmaceuticals - Statement Of Investor Complaints For The Quarter Ended June 2020

    No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
    0110
    Name of the Signatory :- Abhay Raj Singh
    Designation :- Company Secretary and Compliance Officer

  • Jul 10, 2020 17:25 Source: BSE

    IOL Chemicals and Pharmaceuticals - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June 2020

  • Jul 10, 2020 16:45 Source: BSE

    IOL Chemicals and Pharmaceuticals - Shareholding for the Period Ended June 30, 2020

    IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here

  • Jul 08, 2020 12:12 Source: NSE

    IOL Chemicals and Pharmaceuticals Limited

    IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Credit Rating. The CARE Ratings Limited on 7th July 2020 has upgraded the Credit Rating by one notch for the banking facilities availed by the Company, the revised ratings are enclosed herewith for your information.

  • Jul 08, 2020 11:39 Source: BSE

    IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Credit Rating

    The CARE Ratings Limited on 7th July 2020 has upgraded the Credit Rating by one notch for the banking facilities availed by the Company, the revised ratings are enclosed herewith for your information.

  • Jun 30, 2020 17:13 Source: BSE

    IOL Chemicals and Pharmaceuticals - Closure of Trading Window

    Pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s ''Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons'' the Trading Window for dealing in the securities of the Company, shall remain closed for all the designated persons and their immediate relatives from 01st July 2020 till the expiry of 48 hours after the declaration of financial results for quarter ended 30th June 2020 are made public. During the closure of Trading Window, Insiders are also advised not to deal in the shares of the Company. This is for information and record please.

  • Jun 26, 2020 12:51 Source: BSE

    IOL Chemicals and Pharmaceuticals - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NCVI Enterprises Ltd

  • Jun 25, 2020 14:48 Source: BSE

    IOL Chemicals and Pharmaceuticals - Announcement under Regulation 30 (LODR)-Allotment

    The Allotment Committee of the Board of Directors of the Company, in its meeting held today i.e. 25th June 2020 has allotted 4,00,000 (Four Lakh) Fully Paid up Equity Shares of Rs 10/- each at a premium of Rs 195/- per share to M/s NCVI Enterprises Limited (promoter group company) upon exercise of the option attached with the Warrants allotted on 30th March 2019. The said shares shall remain locked-in for a period of 3 years from the date of trading approval. Consequent upon issue of the abovesaid 4,00,000 Equity Shares, the total paid-up capital of the Company stands increased at Rs 58,70,55,020 (Rupees Fifty Eight Crore Seventy Lakh Fifty Five Thousand Twenty Only) divided into 5,87,05,502 (Five Crore Eighty Seven Lakh Five Thousand Five Hundred Two) Fully Paid up Equity Shares of Rs 10/- each. With the conversion of the above said 4,00,000 Warrants into equity shares, now no Warrants are outstanding for conversion. The meeting was concluded at 2:30 PM

  • Jun 23, 2020 11:22 Source: BSE

    IOL Chemicals and Pharmaceuticals - Shareholding for the Period Ended June 17, 2020

    IOL Chemicals & Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 17, 2020. For more details, kindly Click here

  • Jun 20, 2020 9:00 Source: BSE

    IOL Chemicals and Pharmaceuticals - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for NCVI Enterprises Ltd & Others

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Jun 12, 2020
Remark : Audited Results